[转载]Fabry Disease: Developing Drugs for Treatment Guidance for 2024-07-09

I.    INTRODUCTION The purpose of this guidance is to provide recommendations to sponsors regarding clinical trial design features ...

(238)次阅读|(0)个评论

[转载]EMA: NOTIFICATION OF AMENDMENTS AND RELATED MEASUR 2024-06-20

3.  NOTIFICATION   OF    AMENDMENTS   AND    RELATED MEASURES 3.1.  Legal basis and s ...

(279)次阅读|(0)个评论

[转载]Management of Adults and Children receiving CAR T-cell thera 2024-06-11

ABSTRACT: Background: Several commercial and academic autologous chimeric antigen receptor T-cell products targeting ...

(410)次阅读|(0)个评论

[转载]Onasemnogene abeparvovec基因疗法治疗症状性婴儿型脊髓性肌萎缩症1型-part2 2024-05-21

Onasemnogene abeparvovec 基因疗法治疗症状性婴儿型脊髓性肌萎缩症 1 型   Summary  摘要 Background Spinal muscular atrophy is a r ...

(384)次阅读|(0)个评论

[转载]Onasemnogene abeparvovec基因疗法治疗症状性婴儿型脊髓性肌萎缩症1型-part1 2024-05-21

Onasemnogene abeparvovec 基因疗法治疗症状性婴儿型脊髓性肌萎缩症 1 型   Summary  摘要 Background Spinal muscular atrophy type ...

(392)次阅读|(0)个评论

[转载]治疗 SMA 罕见病的孤儿药 Onasemnogene Abeparvovec (Zolgensma ® ) 的真实世界 2024-05-21

治疗 SMA 罕见病的孤儿药 Onasemnogene Abeparvovec (Zolgensma ® ) 的真实世界安全性数据：基于 EMA 不良事件报告系统的药物警戒研究   Abst ...

(486)次阅读|(0)个评论

[转载]JEWELFISH 24月结果 2024-05-21

JEWELFISH: 24-month results from an open-label study in non-treatment-naïve patients with SMA receiving treatment with risdiplam   A ...

(375)次阅读|(0)个评论

查看更多